Safety, Efficacy, And Pharmacodynamic (Pd) Activity Of 12 Weeks Treatment With Oral Rig-I Agonist, Inarigivir (Irig), Plus 48 Weeks Of Tenofovir Alafenamide In Adult Patients With Chronic Hepatitis B: A Phase 2 Collaboration Study

JOURNAL OF HEPATOLOGY(2021)

引用 1|浏览17
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要